Portfolio company HistoSonics was acquired in a $2.25B management-led majority stake acquisition by K5 Global, Bezos Expeditions, Wellington Management, and other investors.
HistoSonics is a medical device company developing non-invasive histotripsy technology for tumor treatment, specifically targeting liver tumors using focused ultrasound
HistoSonics is a medical device company developing non-invasive histotripsy technology for tumor treatment, specifically targeting liver tumors using focused ultrasound.